The system is extremely sensitive: it can detect drugs in amounts 100 times lower than the clinically delivered drug concentrations commonly used
Today, computerized smart systems can deliver drugs intravenously in exact volumes to hospital patients. However, these systems cannot recognize which medications are in the tubing nor can they determine the concentration of the drug in the tubing. This lack of precise information can lead to medication errors with serious consequences.
Now, a new optical device developed by a team of electrical and computer engineering students at the University of Illinois at Urbana-Champaign (UIUC) can identify the contents of the fluid in an intravenous (IV) line in real-time, offering a promising way to improve the safety of IV drug delivery. The team, led by Prof. Brian T. Cunningham, interim director of the Micro and Nanotechnology Laboratory at UIUC, will present its work at The Optical Society’s (OSA) Annual Meeting, Frontiers in Optics (FiO) 2013, being held Oct. 6-10 in Orlando, Fla.
The vulnerability of IV drug-delivery systems due to human error is a chief concern in hospital safety, Cunningham said. Errors can include incorrect dosage, unintentional substitution of one drug for another, and co-delivery of incompatible drugs.
“Up to 61 percent of all life-threatening errors during hospitalization are associated with IV drug therapy,” Cunningham said, citing a recent report. “So for all the really good things hospitals can do, the data shows that mistakes can occasionally happen.”
To approach this problem, Cunningham and colleagues turned to the very small – to structures and processes at the nanoscale (one-billionth of a meter), where novel physical and chemical properties arise. The researchers use a technology called Surface-Enhanced Raman Scattering (SERS), a powerful analytical tool prized for its extreme sensitivity in obtaining molecular signals that can be used to identify chemicals. To determine the identity of a particular IV medication, researchers shine laser light onto a nanostructured gold surface that contains millions of tiny “nano-domes” that are separated from each other by as little as 10 nanometers. The nano-domes are incorporated into the inner surface of IV tubing, where they are exposed to drugs that are dispersed in liquid. They capture the light scattered from drug molecules that are in contact with the nano-domes and use SERS to determine the drug’s molecular signature. Finally, they match the signature to known signatures for the drug in order to confirm the presence of a specific medication in the IV line.
While other groups have demonstrated excellent nanostructured surfaces for SERS, those developed by the Cunningham group are unique because they are inexpensively produced on flexible plastic surfaces by a replica molding process with nanometer scale accuracy.
Early data show that the Cunningham group’s system can identify medications including morphine, methadone, phenobarbital, the sedative promethazine, and mitoxantrone, which is used to treat multiple sclerosis. The system is extremely sensitive: it can detect drugs in amounts 100 times lower than the clinically delivered drug concentrations commonly used. So far, the researchers have also shown their system can sense a two-drug combination, which has its own unique signature.
The next step is further evaluation for combinations of up to ten drugs being delivered at the same time.
The Latest on: Detector for IV delivered drugs
via Google News
The Latest on: Detector for IV delivered drugs
- More paramedics give proactive, non-emergency care as community paramedicine grows in Michiganon October 13, 2021 at 10:15 pm
People usually associate paramedics with emergencies, CPR, and high-speed ambulance trips to the closest hospital with sirens shrieking. But that image is shifting.
- Redwire Providing Critical Navigation Technology to Guide NASA's First Mission to the Trojan Asteroidson October 12, 2021 at 12:03 pm
JACKSONVILLE, Fla., Oct. 12, 2021 /PRNewswire/ -- Redwire Corporation (NYSE: RDW), a leader in mission critical space infrastructure for the next generation space economy, is providing critical ...
- Merck seeks FDA authorization for COVID-19 pillon October 11, 2021 at 10:51 am
The other antiviral drug approved by the FDA to treat COVID-19 is remdesivir, which must be administered by IV or injection and which is only for people hospitalized with COVID-19. The FDA has ...
- Diagnosing Ovarian Cancer with Carbon Nanotubeson October 11, 2021 at 1:31 am
Already, studies have led to novel findings, demonstrating the applications of nanosensors in the early detection and diagnosis of various diseases and drug delivery systems ... the human body and ...
- Air Travel and Cardiovascular Diseaseon October 10, 2021 at 5:00 pm
Although the major manufacturers of ICD technology have not received any reports of delivery of ICD therapy due to exposure to hand-held metal detectors, there is a theoretical risk that the ...
- COVID-19 pill cuts risk of hospitalization, death by half, Merck sayson October 1, 2021 at 10:00 am
The only other antiviral drug approved by the FDA to treat COVID-19 is remdesivir, which must be administered by IV or injection and is only for people hospitalized with COVID-19. The other ...
- The federal split on Covid booster policyon October 1, 2021 at 9:02 am
Democrats in Congress are working to whittle down their drug pricing plans as moderates ... FDA RELEASES INDEPENDENT REPORT EXAMINING MDUFA IV — A report by Booz Allen Hamilton assessing FDA ...
- Shimadzu Receives Vizient Contract for Cardiac and Vascular Interventional Systems and General Radiology Systemson September 21, 2021 at 8:26 am
TORRANCE, Calif., Sept. 21, 2021 /PRNewswire/ -- Shimadzu Medical Systems USA, a leading manufacturer of advanced medical X-ray imaging systems, has announced that the Trinias unity edition ...
- FUJIFILM Medical Systems U.S.A., Inc. Awarded Sole Source Contract for Digital Radiography Systems from U.S. Navyon August 24, 2021 at 6:34 am
featuring next-generation detector technology along with a high quality compact floor mounted room with all of the latest features. The initial DR system delivery and installation is slated for a new ...
- Research Coreson December 1, 2019 at 12:57 am
It provides researchers a place where they can take their drug delivery (e.g. BioMEMS/NEMS or Biosensor ... as well as SE, BSE, and STEM detectors, multiChem Gas Delivery System to deliver precise ...
via Bing News